Platelet Aggregation Devices Market Size, Share, Growth Analysis, By Product(Systems, Reagents, Consumables & Accessories), By Application(Clinical Applications (Cardiovascular Applications, Orthopedic Applications, Other Clinical Applications), Research Applications), By End User(Standalone Hospitals, Diagnostic Laboratories, Research & Academic Institutes, Other End Users), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35A2823 | Region: Global | Published Date: July, 2024
Pages: 219 |Tables: 90 |Figures: 68

Platelet Aggregation Devices Market Insights

Platelet Aggregation Devices Market size was valued at USD 561.19 Million in 2023 and is poised to grow from USD 590.65 Million in 2024 to USD 936.11 Million by 2032, growing at a CAGR of 5.25% during the forecast period (2025-2032).

The global market is experiencing significant growth, propelled by several factors. The increasing incidence of target diseases, coupled with the rapid expansion of the geriatric population worldwide, contributes substantially to the market's upward trajectory. Technological advancements in platelet aggregometry, essential tools for studying platelet function and related disorders, are further driving market growth. Additionally, the rising number of collaborations between industry and academia, along with an upsurge in clinical studies, is fostering innovation and contributing to the expansion of the market.

Despite these positive trends, certain factors pose challenges to market growth. Procedural limitations within the healthcare sector, unfavorable reforms in the U.S. healthcare system, and a shortage of well-trained and skilled professionals represent key impediments to the market's potential advancement. 

Market snapshot - 2024-2031

Global Market Size

USD 533.19 million

Largest Segment

Four-Channel

Fastest Growth

Four-Channel

Growth Rate

5.25% CAGR

Global Platelet Aggregation Devices Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Platelet Aggregation Devices Market Segmental Analysis

Platelet Aggregation Devices Market is segmented on the basis of product, application, end user, and region. Based on product, the market is segmented into Systems, Reagents, and Consumables & Accessories. Based on application, the market is segmented into Clinical Applications (Cardiovascular Applications, Orthopedic Applications, Other Clinical Applications), Research Applications. Based on end user, the market is segmented into Standalone Hospitals, Diagnostic Laboratories, Research & Academic Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. 

Analysis by Product 

Based on our analysis, the Systems segment accounts for the largest share of the Global Platelet Aggregation Devices Market. The elevated growth of this sub-segment is attributed to an increased prevalence of CVDs and the growing number of diagnostic procedures being adopted worldwide. These advances made to platelet aggregation systems, like automation and increased sensitivity, have enabled its wide adoption in a clinical setting. It is the factor of increasing healthcare expenditure and a higher focus on early diagnosis and preventive healthcare that has considerably fueled the growth of the System segment. 

The Reagents segment is the fastest-growing in the global platelet aggregation devices market. This could be attributed to increasing demand for accurate and reliable diagnostic tests, thereby increasing the demand for good-quality reagents for running such tests. Innovations in the formulation of reagents, enhancing the test sensitivity and specificity, also fuel their adoption. Moreover, the demand for advanced reagents will be augmented by the growing trend toward personalized medicine and targeted therapies. Expanding research and development activities in the field of hematology and thrombosis also contribute to this sub-segment's robust growth. 

Global Platelet Aggregation Devices Market By Product

To get detailed analysis on other segments, Request For Free Sample Report

Platelet Aggregation Devices Market Regional Insights

North America asserts dominance in the market, holding the largest market share, primarily attributed to several key factors. The robust presence of device manufacturers in the region significantly contributes to its leadership position. Additionally, the increasing prevalence of target disorders, coupled with a growing geriatric population, fuels the demand for platelet aggregation systems. Technological advancements in platelet aggregometry further bolster the market's prominence in North America.

The Asia Pacific is poised for significant growth in the Platelet Aggregation Devices Market, anticipated to achieve the highest CAGR in the foreseeable future. Several factors contribute to this optimistic outlook, including the region's expanding healthcare infrastructure, increasing awareness about the importance of platelet aggregation testing, and a rising prevalence of cardiovascular and bleeding disorders. Moreover, advancements in medical technologies and an escalating focus on healthcare research and development further propel the demand for platelet aggregation devices in the Asia Pacific.

Global Platelet Aggregation Devices Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Platelet Aggregation Devices Market Dynamics

Drivers

Rise in the Incidence of Cardiovascular Diseases

  • The escalating demand for platelet aggregation devices on a global scale is anticipated to offer substantial growth opportunities for stakeholders in the platelet aggregation devices market. The heightened demand is particularly evident with the increasing burden of chronic and bleeding disorders worldwide. As the prevalence of these medical conditions rises, there is a rapid and parallel surge in the need for advanced diagnostic and monitoring tools, with platelet aggregation devices playing a pivotal role. These devices are integral in assessing platelet function, aiding in the diagnosis and management of various disorders related to coagulation.

Restraints

High Cost of Platelet Aggregation Devices

  • The global platelet aggregation devices market faces obstacles in its growth trajectory due to the high cost associated with these devices and a concurrent shortage of skilled personnel. The substantial expense linked to acquiring platelet aggregation devices poses a challenge for healthcare organizations and facilities, limiting their ability to invest in these advanced diagnostic tools. Moreover, the scarcity of skilled personnel further compounds the issue, impacting the effective utilization and maintenance of these devices.

Request Free Customization of this report to help us to meet your business objectives.

Platelet Aggregation Devices Market Competitive Landscape

The competitive environment of the global Platelet Aggregation Devices market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.

Top Player’s Company Profiles

  • Siemens Healthineers AG (Germany) 
  • F. Hoffmann-La Roche Ltd (Switzerland) 
  • Aggredyne, Inc. (United States) 
  • Helena Laboratories Corporation (United States) 
  • Haemonetics Corporation (United States) 
  • Bio/Data Corporation (United States) 
  • Sysmex Corporation (Japan) 
  • TEM Innovations GmbH (Germany) 
  • Helena Biosciences Europe (United Kingdom) 
  • Chrono-log Corporation (United States) 
  • Helena Biosciences (United States) 
  • Sentinel CH. SpA (Italy) 
  • WerfenLife S.A. (Spain) 
  • Stago (France) 
  • Abbott Laboratories (United States) 
  • Drucker Diagnostics (United States) 
  • Rayto Life and Analytical Sciences Co., Ltd. (China) 
  • Technoclone GmbH (Austria) 
  • Diagnostica Stago, Inc. (United States) 
  • Chronolog Corporation (United States)

Recent Developments

  • In May 2022, Precision BioLogic Inc., a notable developer of hemostasis diagnostic products, introduced the cryocheck Chromogenic Factor IX assay in several global regions, including Canada, the European Union, the United Kingdom, Australia, and New Zealand. This launch highlights the company's commitment to advancing hemostasis diagnostics by providing an innovative and reliable tool for assessing Factor IX levels. The chromogenic assay is expected to contribute to the accurate diagnosis and monitoring of hemophilia patients, reflecting a significant development in the field of coagulation diagnostics.
  • In February 2022, Futura Surgicare Pvt Ltd made a notable entry into the hemostatic products market with the launch of Hemostax, an oxidized regenerated cellulose-based hemostat, under its new vertical, Dolphin Hemostats. Specifically, Hemostax Standard, an absorbable hemostat, was introduced to enhance surgeons' ability to manage and control bleeding more effectively. This product launch signifies Futura Surgicare's strategic expansion into the hemostatic solutions sector, offering surgeons a reliable and advanced tool to address bleeding concerns in various surgical procedures.

Platelet Aggregation Devices Key Market Trends

  • The escalating burden of hemostasis disorders globally is driving a rapid increase in the demand for platelet aggregation devices. This surge in demand is attributed to the critical role that platelet aggregation testing plays in the diagnosis of hemostasis and bleeding disorders. Hemostasis disorders encompass a group of conditions that interfere with the body's blood clotting process, leading to potential complications in coagulation. Platelet aggregation devices are indispensable tools in assessing platelet function and detecting abnormalities in the blood clotting mechanism, thereby facilitating the diagnosis of these disorders. As the prevalence of hemostasis disorders continues to rise, the demand for platelet aggregation devices is anticipated to grow at an accelerated pace worldwide. This prevailing trend is expected to persist throughout the forecast period, becoming a significant driving force behind the sustained growth of the platelet aggregation devices market.

Platelet Aggregation Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

Global Platelet Aggregation Devices marketplace analysis exhibits a dynamic marketplace with some of standout developments and problems. The escalating burden of bleeding disorders and cardiovascular ailments is anticipated to spur the demand for platelet aggregation systems, crucial diagnostic tools in identifying and understanding bleeding disorders. According to data updated by Genetic Home Reference in July 2022, the global incidence of immune thrombocytopenia was estimated at 4 per 100,000 in children and 3 per 100,000 in adults annually. This prevalence underscores the significant impact of bleeding disorders on global health.

Report Metric Details
Market size value in 2022 USD 533.19 million
Market size value in 2031 USD 889.42 million
Growth Rate 5.25%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Product
    • Systems, Reagents, Consumables & Accessories
  • Application
    • Clinical Applications (Cardiovascular Applications, Orthopedic Applications, Other Clinical Applications), Research Applications
  • End User
    • Standalone Hospitals, Diagnostic Laboratories, Research & Academic Institutes, Other End Users
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Siemens Healthineers AG (Germany) 
  • F. Hoffmann-La Roche Ltd (Switzerland) 
  • Aggredyne, Inc. (United States) 
  • Helena Laboratories Corporation (United States) 
  • Haemonetics Corporation (United States) 
  • Bio/Data Corporation (United States) 
  • Sysmex Corporation (Japan) 
  • TEM Innovations GmbH (Germany) 
  • Helena Biosciences Europe (United Kingdom) 
  • Chrono-log Corporation (United States) 
  • Helena Biosciences (United States) 
  • Sentinel CH. SpA (Italy) 
  • WerfenLife S.A. (Spain) 
  • Stago (France) 
  • Abbott Laboratories (United States) 
  • Drucker Diagnostics (United States) 
  • Rayto Life and Analytical Sciences Co., Ltd. (China) 
  • Technoclone GmbH (Austria) 
  • Diagnostica Stago, Inc. (United States) 
  • Chronolog Corporation (United States)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Platelet Aggregation Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Platelet Aggregation Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Platelet Aggregation Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Platelet Aggregation Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Platelet Aggregation Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Platelet Aggregation Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Platelet Aggregation Devices Market size was valued at USD 533.19 million in 2022 and is poised to grow from USD 561.19 million in 2023 to USD 889.42 million by 2031, growing at a CAGR of 5.25% in the forecast period (2024-2031).

The competitive environment of the global Platelet Aggregation Devices market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. 'Siemens Healthineers AG (Germany) ', 'F. Hoffmann-La Roche Ltd (Switzerland) ', 'Aggredyne, Inc. (United States) ', 'Helena Laboratories Corporation (United States) ', 'Haemonetics Corporation (United States) ', 'Bio/Data Corporation (United States) ', 'Sysmex Corporation (Japan) ', 'TEM Innovations GmbH (Germany) ', 'Helena Biosciences Europe (United Kingdom) ', 'Chrono-log Corporation (United States) ', 'Helena Biosciences (United States) ', 'Sentinel CH. SpA (Italy) ', 'WerfenLife S.A. (Spain) ', 'Stago (France) ', 'Abbott Laboratories (United States) ', 'Drucker Diagnostics (United States) ', 'Rayto Life and Analytical Sciences Co., Ltd. (China) ', 'Technoclone GmbH (Austria) ', 'Diagnostica Stago, Inc. (United States) ', 'Chronolog Corporation (United States)'

The escalating demand for platelet aggregation devices on a global scale is anticipated to offer substantial growth opportunities for stakeholders in the platelet aggregation devices market. The heightened demand is particularly evident with the increasing burden of chronic and bleeding disorders worldwide. As the prevalence of these medical conditions rises, there is a rapid and parallel surge in the need for advanced diagnostic and monitoring tools, with platelet aggregation devices playing a pivotal role. These devices are integral in assessing platelet function, aiding in the diagnosis and management of various disorders related to coagulation.

The escalating burden of hemostasis disorders globally is driving a rapid increase in the demand for platelet aggregation devices. This surge in demand is attributed to the critical role that platelet aggregation testing plays in the diagnosis of hemostasis and bleeding disorders. Hemostasis disorders encompass a group of conditions that interfere with the body's blood clotting process, leading to potential complications in coagulation. Platelet aggregation devices are indispensable tools in assessing platelet function and detecting abnormalities in the blood clotting mechanism, thereby facilitating the diagnosis of these disorders. As the prevalence of hemostasis disorders continues to rise, the demand for platelet aggregation devices is anticipated to grow at an accelerated pace worldwide. This prevailing trend is expected to persist throughout the forecast period, becoming a significant driving force behind the sustained growth of the platelet aggregation devices market.

North America asserts dominance in the market, holding the largest market share, primarily attributed to several key factors. The robust presence of device manufacturers in the region significantly contributes to its leadership position. Additionally, the increasing prevalence of target disorders, coupled with a growing geriatric population, fuels the demand for platelet aggregation systems. Technological advancements in platelet aggregometry further bolster the market's prominence in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Platelet Aggregation Devices Market

Report ID: SQMIG35A2823

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE